Legionnaires' Disease Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan)
Conditions: Legionnaires' Disease; Legionella Pneumophila InfectionsIntervention: Drug: Azithromycin IVSponsor: PfizerEnrolling by invitation - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2013 Category: Research Source Type: clinical trials
Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan)
Conditions: Legionnaires' Disease; Legionella Pneumophila InfectionsIntervention: Drug: Azithromycin IVSponsor: PfizerEnrolling by invitation - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2013 Category: Research Source Type: clinical trials
Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan)
Conditions: Legionnaires' Disease; Legionella Pneumophila InfectionsIntervention: Drug: Azithromycin IVSponsor: PfizerEnrolling by invitation - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2013 Category: Research Source Type: clinical trials
Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan)
Conditions: Legionnaires' Disease; Legionella Pneumophila InfectionsIntervention: Drug: Azithromycin IVSponsor: PfizerActive, not recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2013 Category: Research Source Type: clinical trials
